[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346326-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346326-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-impact-of-the-covid-19-pandemic-on-patients-with-breast-cancer-diagnostic-delays-and-disease-progression-a-retrospective-study","The Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study","","Breast cancer care in Shiraz, Iran was evaluated to determine how the COVID-19 pandemic related to diagnosis timing and disease parameters. A retrospective cohort compared patients diagnosed before vs. after the pandemic onset (September 2018 to March 2021), analyzing demographic, clinical, and management variables. Post-pandemic patients showed significantly larger initial tumor sizes and different cancer-stage distributions. Stage 2 and stage 3 proportions increased after the pandemic, supporting worse presentation. Results included 1,435 total cases (811 pre, 624 post), with significance set at P\u003C0.05.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-impact-of-the-covid-19-pandemic-on-patients-with-breast-cancer-diagnostic-delays-and-disease-progression-a-retrospective-study/346326/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-impact-of-the-covid-19-pandemic-on-patients-with-breast-cancer-diagnostic-delays-and-disease-progression-a-retrospective-study/346326.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s primary aim?","Question",{"text":63,"@type":64},"To determine the correlation between the COVID-19 pandemic and various breast cancer parameters, focusing on diagnosis and disease progression effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients grouped in the retrospective study?",{"text":68,"@type":64},"Patients were divided into two groups based on diagnosis timing: before the pandemic and after the start of the COVID-19 pandemic (September 2018 to March 2021).",{"name":70,"@type":61,"acceptedAnswer":71},"What major differences were found after the pandemic?",{"text":72,"@type":64},"Patients presented with significantly larger tumors, increased axillary involvement, and more advanced disease stages compared with the pre-pandemic group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346326,1790153360,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","IJMS  \nVol 51, No 1, January 2026  \nOriginal Article  \nThe Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study  \nAlireza Rezvani1,2 , MD; Reza Heydarzadeh3 , MD; Reza Golchin Vafa3 , MD; Sina Sohrabizadeh4 , MD; Mohammad Hossein Rahmani3 , MD; Vahid Zangouri5 , MD; Hossein Molavi Vardanjani6 , MD, MPH; Hourshad Zarifkar3 , MD; Houman Zarifkar3 , MD; Houyar Zarifkar3 , MD; Reza Shahriarirad2,7, MD  \n1Department of Internal Medicine, Division of Hematology and Oncology, Shiraz University of Medical Sciences, Shiraz, Iran;  \n2Department of Surgery, Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;  \n3Department of Internal Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;  \n4Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;  \n5Department of General Surgery, Division of Surgical Oncology, Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;  \n6Department of Epidemiology and Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;  \n7Department of Surgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \nCorrespondence:  \nReza Shahriarirad, MD;  \nShiraz University of Medical Sciences, Zand Blvd. , Postal Code: 7134814336, Shiraz, Iran  \nEmail: [r.shahriari1995@gmail.com](r.shahriari1995@gmail.com)  \n[Received: 25 January 2025](Received: 25 January 2025)  \n[Revised: 03 July 2025](Revised: 03 July 2025)  \n[Accepted: 11 July 2025](Accepted: 11 July 2025)  \n\n| \u003Cbr>What’s Known\u003Cbr>• The COVID-19 pandemic led to delaysin breast cancer diagnosis and treatment, resulting in patients presenting with larger tumors, increased axillary involvement, and more advanced disease stages.\u003Cbr>• Previous studies reported decreased cancer screenings and delayed diagnoses caused by COVID-19 restrictions, leading to more advanced disease at presentation.\u003Cbr>\u003Cbr>What’s New |\n| --- |\n| • This study provided unique regional data from Shiraz, Iran, quantifying the rise in tumor size, axillary lymph node involvement, and advanced staging among breast cancer patients during the pandemic.\u003Cbr>• The findings highlighted a significant post-pandemic decline in the utilization of adjuvant chemotherapy and intraoperative radiotherapy, underscoring critical gaps in subsequent patient management. |\n\nAbstract  \nBackground: Breast cancer is the most frequent malignancy among women. The COVID-19 pandemic significantly impacted healthcare systems, potentially affecting the management of this disease. Due to the critical importance of early diagnosis and treatment, and the limited data on the pandemic’s specific effects, this study aimed to determine the correlation between the COVID-19 pandemic and various breast cancer parameters. Methods: This retrospective study included patients with breast cancer in Shiraz, Iran. Patients were divided into two groups, including those diagnosed before and after the start of the COVID-19 pandemic (from September 2018 to March 2021). Variables included demographic, clinical, and management features. Continuous variables were reported as mean±SD, and the categorical data were reported as frequency and percentage. The significance level was set as P\u003C0.05.  \nResults: The study documented 1,435 patients: 811 patients were diagnosed before the pandemic, and 624 patients were diagnosed after. The mean initial tumor size at the time of diagnosis was significantly larger in the post-pandemic group than the pre-pandemic group (2.29±1.44 vs. 2.11±1.39 cm, respectively; P=0.001). The distribution of cancer stages also differed significantly (P=0.001). While the prevalence of stage 1 disease was similar between groups (30.1% vs. 28.9%), the prevalence of stage 2 (14.8% vs. 8.5%) and stage 3 (10.1% vs. 7.0%) was significantly higher in the post","cbCaigGXIHAPfG8p","https://ap.wps.com/l/cbCaigGXIHAPfG8p","pdf",348131,"English","# What’s Known\n# What’s New\n# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# COVID-19 impact on breast cancer care","[{\"question\":\"What was the study’s primary aim?\",\"answer\":\"To determine the correlation between the COVID-19 pandemic and various breast cancer parameters, focusing on diagnosis and disease progression effects.\"},{\"question\":\"How were patients grouped in the retrospective study?\",\"answer\":\"Patients were divided into two groups based on diagnosis timing: before the pandemic and after the start of the COVID-19 pandemic (September 2018 to March 2021).\"},{\"question\":\"What major differences were found after the pandemic?\",\"answer\":\"Patients presented with significantly larger tumors, increased axillary involvement, and more advanced disease stages compared with the pre-pandemic group.\"}]","The Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study | PDF",1790060931,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92c3dcffaf9d9b8c49d1faa6bb7d6299.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/402dac681e59f69c465c3c0d4e243839.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58a50c8b16f7d68c1d4a5cd3e8bd9555.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4254a90b14375ac6d1531806600c6f7b.webp",980,1385]